|
YOKNEAM, Israel & TORONTO--(BUSINESS WIRE)--March 15, 2005--Syneron Medical Ltd. (Nasdaq:ELOS - News) today announced the closing of the previously announced secondary offering by selling shareholders of 7,000,000 of its ordinary shares at $28.00 per share. The selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,050,000 of their ordinary shares.
The offer is being made only by means of a prospectus. Lehman Brothers Inc. and CIBC World Markets Corp. acted as joint book-running managers of the offering with Citigroup Global Markets Inc. serving as a joint lead manager. Stephens Inc., Thomas Weisel Partners LLC, and C.E. Unterberg, Towbin LLC acted as co-managers. Copies of the prospectus relating to the offering may be obtained from Lehman Brothers Inc. c/o ADP Financial Services, Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 631-254-7106.
A registration statement relating to these securities has been filed and declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
|